Clinical Trial Update: Use of Biperiden for the Prevention of Post-traumatic Epilepsy [Phase 3]

View source ↗

Summary

Phase 3 trial investigating biperiden to prevent post-traumatic epilepsy in traumatic brain injury was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Biperiden (biperiden)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Traumatic Brain Injury | Phase 3 | Status: TERMINATED